DVB Technologies
DVB Technologies

'Peanut patch' could help kids with peanut allergy

Embargoed until: Publicly released:

Kids who are allergic to peanuts may benefit from a 'peanut patch' - a skin patch containing peanut protein - applied daily, according to international and Australian research. The study across 31 international sites, including three in Australia, found that 35 per cent of children who received the peanut patch responded to the treatment, compared to just 13 percent with the placebo patch. The results were statistically significant but they did not quite meet an agree pre-trial definition of a clinically significant response that was recommended by the US Food and Drug Administration. An accompanying editorial says doctors will have to determine with patients whether this response rate makes the peanut patch worthwhile.

Journal/conference: JAMA

Link to research (DOI): 10.1001/jama.2019.1113

Organisation/s: The University of Sydney, Children's Hospital at Westmead, The University of Western Australia, Children’s Hospital Colorado, USA

Funder: The study was sponsored by DBV Technologies and conducted under an Investigational New Drug application to the US FDA and Clinical Trial Approvals in Canada and European countries.

Attachments:

Note: Not all attachments are visible to the general public

  • JAMA
    Web page
    Please link to the article in online versions of your report (the URL will go live after the embargo ends).

News for:

Australia
International
NSW
WA

Media contact details for this story are only visible to registered journalists.